Molecular pharmaceuticsAntibodiesMonoclonalProtein AggregatesHydrogen-Ion ConcentrationTemperature
Deconvoluting Biophysical Factors that Influence Long-Term Aggregation Rates of High-Concentration Monoclonal Antibody Formulations.
James K Forder, Erinc Sahin, Christopher J Roberts
Published: 202610.1021/acs.molpharmaceut.5c01398
Abstract
Efficient determination of developable protein drug candidates and stable solution conditions is a key challenge in industrial drug development. Protein aggregation is difficult to predict and can lead to challenges in manufacturing, storage, and pat…
Preview only. Read the full abstract at the source